Health Care & Life Sciences » Biotechnology | Jinhe Biotechnology Co. Ltd.

Jinhe Biotechnology Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
735
836
1,245
1,481
1,441
1,610
Cost of Goods Sold (COGS) incl. D&A
488
590
903
1,000
921
1,041
Gross Income
247
246
342
481
519
569
SG&A Expense
131
153
191
251
306
338
EBIT
110
83
139
222
209
218
Unusual Expense
-
-
-
-
11
12
Non Operating Income/Expense
7
9
8
18
13
40
Interest Expense
3
3
28
27
40
53
Pretax Income
108
94
129
215
147
195
Income Tax
18
14
13
41
37
30
Equity in Affiliates
-
-
-
-
-
-
Consolidated Net Income
91
80
116
174
110
164
Net Income
90
77
105
164
108
164
Net Income After Extraordinaries
90
77
105
164
108
164
Net Income Available to Common
90
77
105
164
108
164
EPS (Basic)
0.17
0.14
0.19
0.26
0.17
0.26
Basic Shares Outstanding
545
545
545
631
635
635
EPS (Diluted)
0.17
0.14
0.19
0.26
0.17
0.26
Diluted Shares Outstanding
545
545
545
631
635
635
EBITDA
147
125
193
277
283
306
Other Operating Expense
7
9
12
8
4
12
Non-Operating Interest Income
6
3
2
1
2
1
Minority Interest Expense
-
3
11
10
2
1

About Jinhe Biotechnology Co.

View Profile
Address
No. 71 Xinping Road
Hohhot Inner Mongolia 010200
China
Employees -
Website http://www.jinhe.com.cn
Updated 07/08/2019
Jinhe Biotechnology Co., Ltd. engages in the manufacture and sale of veterinary medicines. Its products include chlortetracycline feed grade, chlortetracycline hydrochloride, and salinomycin. The company was founded on March 14, 1990 and is headquartered in Hohhot, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.